Coronary Artery Disease. We see you.

For personal use only

ASX ANNOUNCEMENT

MARKET RELEASE

27 July 2022

Updated Appendix 4C for Q4 FY22

Artrya Limited (ASX: AYA), ("Artrya" or the "Company"), a medical technology company focused on commercialising its patented artificial intelligence platform, advises that there was an error on page 1 of the Appendix 4C Cash Flow Report for the quarter ended 30 June 2022 (Appendix 4C). On page 1 of the Appendix 4C, some of the year to date individual items for cash flows from operating activities were not correct and have now been corrected, however the net cash from / (used in) operating activities total for the current quarter and year to date (12 Months) have not changed. There are no other changes to the Appendix 4C. An updated Appendix 4C is now attached.

This announcement was approved by the Company's Managing Director, John Barrington, on behalf of the Artrya

Board.

For further information please contact

Investor Enquiries:

Media Enquiries:

John Barrington

Brett McCarthy

Artrya Limited

Artrya Limited

+61 419 850 502

+61 401 704 451

investors@artrya.com

brett.mccarthy@artrya.com

About Artrya

Based in Perth, Australia, Artrya was founded in 2018 and commenced operations in early 2019. Artrya Ltd is listed on the Australian Securities Exchange (ASX: AYA).

Artrya is an applied artificial intelligence healthcare company that works alongside clinicians to improve the diagnosis of coronary heart disease and develop a holistic overview of a patient at risk. The company has developed deep learning algorithms that will allow for the prediction and prevention of acute coronary events.

For more information, see www.artrya.com

Artrya Limited

ACN 624 005 741

1257 Hay Street West Perth WA 6005 PO Box 567 West Perth WA 6872 www.artrya.com

T: +61 8 6478 7816

For personal use only

Rule 4.7B

Appendix 4C

Quarterly cash flow report for entities subject to Listing Rule 4.7B

Name of entity

Artrya Limited

ABN

Quarter ended ("current quarter")

53 624 005 741

30 June 2022

Consolidated statement of cash flows

Current quarter

Year to date

$A'000

(12 months)

$A'000

1.

Cash flows from operating activities

1.1

Receipts from customers

-

-

1.2

Payments for

(a)

research and development

(1,110)

(2,589)

(b) product manufacturing and operating

(562)

(2,746)

costs

(c)

advertising and marketing

(397)

(2,099)

(d)

leased assets

(78)

(85)

(e)

staff costs

(1,696)

(5,023)

(f) administration and corporate costs

(371)

(1,507)

1.3

Dividends received (see note 3)

-

1.4

Interest received

20

30

1.5

Interest and other costs of finance paid

(13)

(13)

1.6

Income taxes paid

-

1.7

Government grants and tax incentives

15

992

1.8

Other (provide details if material)

-

-

1.9

Net cash from / (used in) operating

(4,192)

(13,040)

activities

2.

Cash flows from investing activities

2.1

Payments to acquire or for:

(a)

entities

-

-

(b)

businesses

-

-

(c) property, plant and equipment

(1,007)

(1,906)

(d)

investments **

9,000

(20,000)

(e)

intellectual property

(75)

(243)

(f)

other non-current assets

-

-

ASX Listing Rules Appendix 4C (17/07/20)

Page 1

+ See chapter 19 of the ASX Listing Rules for defined terms.

For personal use only

Appendix 4C

Quarterly cash flow report for entities subject to Listing Rule 4.7B

Consolidated statement of cash flows

Current quarter

Year to date

$A'000

(12 months)

$A'000

2.2

Proceeds from disposal of:

(a)

entities

-

-

(b)

businesses

-

-

(c)

property, plant and equipment

4

4

(d)

investments

-

-

(e)

intellectual property

-

-

(f)

other non-current assets

-

-

2.3

Cash flows from loans to other entities

-

-

2.4

Dividends received (see note 3)

-

-

2.5

Other (provide details if material)

-

-

2.6

Net cash from / (used in) investing

7,922

(22,145)

activities

3. Cash flows from financing activities

3.1 Proceeds from issues of equity securities

(excluding convertible debt securities)

-

40,000

3.2

Proceeds from issue of convertible debt

-

-

securities

3.3

Proceeds from exercise of options

-

10

3.4

Transaction costs related to issues of

-

(3,023)

equity securities or convertible debt

securities

3.5

Proceeds from borrowings

-

-

3.6

Repayment of borrowings

-

-

3.7

Transaction costs related to loans and

-

-

borrowings

3.8

Dividends paid

-

-

3.9

Other (rental incentives)

898

898

3.10

Net cash from / (used in) financing

898

37,885

activities

4. Net increase / (decrease) in cash and cash equivalents for the period

4.1 Cash and cash equivalents at beginning of

period

10,925

12,853

4.2

Net cash from / (used in) operating

(4,192)

(13,106)

activities (item 1.9 above)

4.3

Net cash from / (used in) investing activities

7,922

(22,145)

(item 2.6 above)

ASX Listing Rules Appendix 4C (17/07/20)

Page 2

+ See chapter 19 of the ASX Listing Rules for defined terms.

Appendix 4C Quarterly cash flow report for entities subject to Listing Rule 4.7B

only

Consolidated statement of cash flows

  1. Net cash from / (used in) financing activities (item 3.10 above)
  2. Effect of movement in exchange rates on cash held
  3. Cash and cash equivalents at end of period **

Current quarter

Year to date

$A'000

(12 months)

$A'000

898

37,885

5

5

15,558

15,558

For personal use

5.

Reconciliation of cash and cash

Current quarter

Previous quarter

equivalents

$A'000

$A'000

at the end of the quarter (as shown in the

consolidated statement of cash flows) to the

related items in the accounts

5.1

Bank balances **

15,558

10,925

5.2

Call deposits

-

-

5.3

Bank overdrafts

-

-

5.4

Other (provide details)

-

-

5.5

Cash and cash equivalents at end of

15,558

10,925

quarter (should equal item 4.6 above)

6.

Payments to related parties of the entity and their

Current quarter

associates

$A'000

6.1

Aggregate amount of payments to related parties and their

279

associates included in item 1

6.2

Aggregate amount of payments to related parties and their

-

associates included in item 2

Note: if any amounts are shown in items 6.1 or 6.2, your quarterly activity report must include a description of, and an explanation for, such payments.

ASX Listing Rules Appendix 4C (17/07/20)

Page 3

+ See chapter 19 of the ASX Listing Rules for defined terms.

use only

Appendix 4C

Quarterly cash flow report for entities subject to Listing Rule 4.7B

7.

Financing facilities

Total facility

Amount drawn at

Note: the term "facility' includes all forms of financing

amount at quarter

quarter end

arrangements available to the entity.

end

$A'000

Add notes as necessary for an understanding of the

$A'000

sources of finance available to the entity.

7.1

Loan facilities

-

-

7.2

Credit standby arrangements

-

-

7.3

Other (see table 7.6 below)

285

84

7.4

Total financing facilities

285

84

7.5

Unused financing facilities available at quarter end

201

7.6 Include in the box below a description of each facility above, including the lender, interest rate, maturity date and whether it is secured or unsecured. If any additional financing facilities have been entered into or are proposed to be entered into after quarter end, include a note providing details of those facilities as well.

Other financing facilities - corporate credit cards

Facility

Facility limit

Amount drawn

Interest rate

Secured

$A'000

$A'000

American Express

160

2

6.99% p.a.

No

- credit cards

Bankwest - credit

125

3

17.99% p.a.

Guarantee deposit

cards

285

5

personal

8. Estimated cash available for future operating activities

8.1 Net cash from / (used in) operating activities (item 1.9)

8.2 Cash and cash equivalents at quarter end (item 4.6)

8.3 Unused finance facilities available at quarter end (item 7.5)

8.4 Total available funding (item 8.2 + item 8.3) **

8.5 Estimated quarters of funding available (item 8.4 divided by item 8.1) **

$A'000

(4,192)

15,558

201

15,759

3.76

For

Note: if the entity has reported positive net operating cash flows in item 1.9, answer item 8.5 as "N/A". Otherwise, a figure for the estimated quarters of funding available must be included in item 8.5.

8.6 If item 8.5 is less than 2 quarters, please provide answers to the following questions:

8.6.1 Does the entity expect that it will continue to have the current level of net operating cash flows for the time being and, if not, why not?

Answer:

8.6.2 Has the entity taken any steps, or does it propose to take any steps, to raise further cash to fund its operations and, if so, what are those steps and how likely does it believe that they will be successful?

Answer:

ASX Listing Rules Appendix 4C (17/07/20)

Page 4

+ See chapter 19 of the ASX Listing Rules for defined terms.

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Artrya Ltd. published this content on 27 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 July 2022 08:31:09 UTC.